Vabicaserin
Vabicaserin (codenamed SCA-136) is an investigational antipsychotic and anorectic that was under development by Wyeth. As of 2010, it is no longer in clinical trials for the treatment of psychosis.
Vabicaserin (codenamed SCA-136) is an investigational antipsychotic and anorectic that was under development by Wyeth. As of 2010, it is no longer in clinical trials for the treatment of psychosis.
Vabicaserin (codenamed SCA-136) is an investigational antipsychotic and anorectic that was under development by Wyeth. As of 2010, it is no longer in clinical trials for the treatment of psychosis.
Source: Wikipedia "Vabicaserin" · CC BY-SA 4.0
Share this article: X · Bluesky